Publication | Open Access

Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial

ThrombosisCerebral Vascular RegulationCardiovascular DiseaseMedicineStroke-related ConditionCerebrovascular DiseaseRehabilitationNeurologyCerebrovascular InterventionCerebral Blood FlowSecondary Stroke PreventionStrokePublic HealthIschemic SyndromeDose-finding TrialFactor Xia Inhibition